Jinghua Pharmaceutical Group Co., Ltd. (002349.SZ)
CNY 6.79
(1.19%)
CNY 6.79
(1.19%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -885.75 Million CNY | 2.73% |
| 2022 | -910.64 Million CNY | -99.27% |
| 2021 | -456.99 Million CNY | -60.68% |
| 2020 | -284.42 Million CNY | -235.2% |
| 2019 | 210.36 Million CNY | 3.86% |
| 2018 | 202.53 Million CNY | 306.98% |
| 2017 | -97.85 Million CNY | 73.2% |
| 2016 | -365.08 Million CNY | 2.58% |
| 2015 | -374.77 Million CNY | 49.79% |
| 2014 | -746.35 Million CNY | -1128.31% |
| 2013 | -60.76 Million CNY | 67.0% |
| 2012 | -184.14 Million CNY | 49.68% |
| 2011 | -365.95 Million CNY | 8.92% |
| 2010 | -401.79 Million CNY | -1152.2% |
| 2009 | -32.08 Million CNY | -708.38% |
| 2008 | 5.27 Million CNY | -69.19% |
| 2007 | 17.12 Million CNY | -66.52% |
| 2006 | 51.13 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -861.02 Million CNY | 2.79% |
| 2024 Q3 | -1.28 Billion CNY | -32.68% |
| 2024 Q2 | -967.6 Million CNY | -12.38% |
| 2023 Q4 | -885.75 Million CNY | -7.89% |
| 2023 Q2 | -740.24 Million CNY | 17.77% |
| 2023 Q1 | -900.25 Million CNY | 1.14% |
| 2023 FY | -885.75 Million CNY | 2.73% |
| 2023 Q3 | -820.99 Million CNY | -10.91% |
| 2022 Q2 | -479.19 Million CNY | -2.02% |
| 2022 Q1 | -469.7 Million CNY | -2.78% |
| 2022 FY | -910.64 Million CNY | -99.27% |
| 2022 Q4 | -910.64 Million CNY | -41.0% |
| 2022 Q3 | -645.85 Million CNY | -34.78% |
| 2021 FY | -456.99 Million CNY | -60.68% |
| 2021 Q3 | -348.2 Million CNY | -3.34% |
| 2021 Q2 | -336.94 Million CNY | 5.6% |
| 2021 Q4 | -456.99 Million CNY | -31.24% |
| 2021 Q1 | -356.92 Million CNY | -25.49% |
| 2020 Q1 | 140.84 Million CNY | -33.05% |
| 2020 Q3 | -266.42 Million CNY | -386.16% |
| 2020 Q4 | -284.42 Million CNY | -6.76% |
| 2020 FY | -284.42 Million CNY | -235.2% |
| 2020 Q2 | 93.1 Million CNY | -33.9% |
| 2019 Q2 | 233.18 Million CNY | 0.43% |
| 2019 Q4 | 210.36 Million CNY | 1.37% |
| 2019 FY | 210.36 Million CNY | 3.86% |
| 2019 Q1 | 232.17 Million CNY | 14.63% |
| 2019 Q3 | 207.52 Million CNY | -11.0% |
| 2018 Q1 | -23.63 Million CNY | 75.85% |
| 2018 FY | 202.53 Million CNY | 306.98% |
| 2018 Q2 | 10.02 Million CNY | 142.4% |
| 2018 Q3 | 172.16 Million CNY | 1617.93% |
| 2018 Q4 | 202.53 Million CNY | 17.64% |
| 2017 Q1 | -217.96 Million CNY | 40.3% |
| 2017 Q4 | -97.85 Million CNY | -52.06% |
| 2017 FY | -97.85 Million CNY | 73.2% |
| 2017 Q3 | -64.35 Million CNY | 70.32% |
| 2017 Q2 | -216.8 Million CNY | 0.53% |
| 2016 FY | -365.08 Million CNY | 2.58% |
| 2016 Q4 | -365.08 Million CNY | 12.31% |
| 2016 Q3 | -416.34 Million CNY | 3.09% |
| 2016 Q1 | -442.42 Million CNY | -18.05% |
| 2016 Q2 | -429.6 Million CNY | 2.9% |
| 2015 Q4 | -374.77 Million CNY | 41.33% |
| 2015 FY | -374.77 Million CNY | 49.79% |
| 2015 Q2 | -653.72 Million CNY | 2.95% |
| 2015 Q3 | -638.81 Million CNY | 2.28% |
| 2015 Q1 | -673.58 Million CNY | 9.75% |
| 2014 FY | -746.35 Million CNY | -1128.31% |
| 2014 Q4 | -746.35 Million CNY | -1410.92% |
| 2014 Q3 | -49.39 Million CNY | 10.98% |
| 2014 Q2 | -55.49 Million CNY | -11.87% |
| 2014 Q1 | -49.6 Million CNY | 18.36% |
| 2013 FY | -60.76 Million CNY | 67.0% |
| 2013 Q1 | -143.99 Million CNY | 21.81% |
| 2013 Q2 | -106.46 Million CNY | 26.06% |
| 2013 Q3 | -68.32 Million CNY | 35.83% |
| 2013 Q4 | -60.76 Million CNY | 11.07% |
| 2012 Q3 | -195.39 Million CNY | 15.46% |
| 2012 Q1 | -368.07 Million CNY | -0.58% |
| 2012 Q4 | -184.14 Million CNY | 5.75% |
| 2012 FY | -184.14 Million CNY | 49.68% |
| 2012 Q2 | -231.13 Million CNY | 37.21% |
| 2011 FY | -365.95 Million CNY | 8.92% |
| 2011 Q3 | -380.9 Million CNY | 8.13% |
| 2011 Q4 | -365.95 Million CNY | 3.92% |
| 2011 Q2 | -414.61 Million CNY | -6.1% |
| 2011 Q1 | -390.78 Million CNY | 2.74% |
| 2010 Q2 | -387.29 Million CNY | 4.96% |
| 2010 FY | -401.79 Million CNY | -1152.2% |
| 2010 Q3 | -381.93 Million CNY | 1.38% |
| 2010 Q4 | -401.79 Million CNY | -5.2% |
| 2010 Q1 | -407.49 Million CNY | -1169.98% |
| 2009 Q4 | -32.08 Million CNY | -100.35% |
| 2009 FY | -32.08 Million CNY | -708.38% |
| 2009 Q2 | -5.06 Million CNY | 0.0% |
| 2009 Q3 | -16.01 Million CNY | -216.37% |
| 2008 Q4 | 5.27 Million CNY | 0.0% |
| 2008 FY | 5.27 Million CNY | -69.19% |
| 2007 FY | 17.12 Million CNY | -66.52% |
| 2006 FY | 51.13 Million CNY | 0.0% |